Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
TCRX —
TSCAN THERAPEUTICS INC
CUSIP: 89854M101 · Held by 2 superinvestors · Combined value: $1,303,946
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $1,141,069 | 1,141,069 | ADD | +311,150 |
| 2 | Ken Griffin | 0.0% | $162,877 | 162,877 | REDUCE | -227,870 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +311,150 | +37.5% |
| Ken Griffin | REDUCE | -227,870 | -58.3% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +37,863 | +4.8% |
| Ken Griffin | ADD | +171,760 | +78.4% |
Who Owns TCRX? Superinvestor Holdings
TSCAN THERAPEUTICS INC is held by 2 tracked superinvestors, with a combined position value of $1 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.